Across the European Union, tobacco control policy has historically focused on reducing smoking through restrictions, taxation, and public health campaigns. These measures have contributed to steady declines in smoking prevalence over time. However, the pace of change has varied across Member States, and smoking remains a significant public health concern.
Within this broader context, Sweden has attracted attention for achieving comparatively low smoking rates and reduced levels of smoking-related disease. As EU policymakers review frameworks such as the Tobacco Products Directive (TPD) and the Tobacco Excise Directive (TED), Sweden’s experience is increasingly referenced in discussions about how different regulatory approaches may influence public health outcomes.
A Distinct Policy Approach
Sweden’s progress in reducing smoking has not been driven by a single intervention. Rather, it reflects a combination of regulatory measures, cultural factors, and the availability of alternatives to combustible tobacco.
Public health strategies across Europe have often emphasised restriction, limiting access, tightening rules, and increasing costs associated with smoking. These approaches remain central to tobacco control. However, Sweden’s experience suggests that behavioural outcomes may also be influenced by how policy frameworks account for the availability and perception of alternative products.
Johan Nissinen, former Member of the European Parliament and now working with the Global Institute for Novel Nicotine (GINN), has reflected on this contrast based on his experience in EU policy discussions.
“In many committee meetings and stakeholder briefings, the emphasis was often on being stricter—introducing more bans and tighter restrictions,” Nissinen noted in conversations with GINN. “Sweden took a different approach, not by reducing its focus on smoking, but by considering how people actually change behaviour.”
This distinction highlights an important element of regulatory design: the difference between restricting harmful behaviours and enabling transitions away from them.
The Role of Product Differentiation
One feature of Sweden’s approach is the clearer differentiation between product categories. Scientific and regulatory discussions increasingly recognise that not all nicotine products present the same level of risk, particularly when comparing combustible tobacco with non-combustible alternatives.
While all nicotine products carry some level of risk, the absence of combustion in certain product categories is associated with reduced exposure to many harmful substances found in cigarette smoke. This distinction has become an important consideration in both research and policy analysis.
In Sweden, regulatory frameworks and market conditions have reflected these differences more explicitly than in some other jurisdictions. This has contributed to an environment in which adult consumers may perceive meaningful distinctions between products.
Nissinen highlighted the importance of this clarity:
“You do not reduce smoking by removing alternatives,” he explained. “You reduce smoking by making lower-risk options accessible to adults who already smoke, while maintaining appropriate safeguards.”
This perspective aligns with broader discussions on risk-proportionate regulation, where policy frameworks aim to reflect differences in product characteristics and associated health risks.
Access and Behavioural Change
Behavioural research consistently shows that individuals rarely change long-established habits instantly. Transitions often occur gradually, influenced by factors such as availability, affordability, and perceived benefit.
In Sweden, access to non-combustible nicotine products has been a notable feature of the policy environment. For adult smokers, the presence of alternatives may provide additional pathways for reducing or discontinuing cigarette use over time.
This does not imply that such products are without risk or that they should be promoted without regulation. Rather, it highlights the importance of considering how access and product differentiation may influence real-world behaviour.
A Focus on Outcomes
Public health policy can be evaluated in different ways. One approach focuses on the strength of regulatory measures, such as the number of restrictions or the strictness of controls. Another focuses on outcomes, including changes in smoking prevalence and reductions in disease.
Sweden’s experience is often discussed in terms of measurable outcomes. Lower smoking rates and reduced smoking-related disease provide a basis for examining how different policy environments may influence public health.
Nissinen framed this issue in terms of practical results:
“The outcomes in Sweden are visible,” he noted. “Smoking is becoming less common, and the associated health risks are declining. This is not a theoretical discussion—it reflects measurable changes.”
This emphasis on outcomes aligns with evidence-based policymaking, where the effectiveness of regulatory frameworks is assessed through their real-world impact.
Implications for EU Policy
As the European Union reviews the TPD and TED, policymakers face the challenge of designing frameworks that are both protective and effective. This includes maintaining strong measures to prevent youth initiation while also addressing the needs of adults who currently smoke.
The Swedish case does not provide a single model that can be directly applied across all Member States. Differences in culture, market conditions, and regulatory environments must be taken into account. However, it does offer a point of reference for examining how policy design, product availability, and behavioural factors interact.
In particular, it highlights the potential importance of aligning regulatory frameworks with evidence on risk and behaviour, while ensuring that policy signals are clear and consistent.
Looking Ahead
Reducing smoking-related harm remains a central objective of EU public health policy. Achieving this goal requires regulatory systems that are responsive to both scientific evidence and real-world behaviour.
Sweden’s experience suggests that outcomes may be influenced not only by the strength of restrictions but also by how policy frameworks support behavioural change. Clear product differentiation, access to alternatives, and a focus on measurable results are all elements that have been part of this environment.
As EU policy continues to evolve, examining these factors may help inform discussions on how to design regulatory frameworks that effectively reduce smoking-related disease over time.
In this context, ensuring that policy follows evidence and that outcomes remain central to evaluation, may play an important role in shaping the next phase of tobacco and nicotine regulation in Europe.
